Everolimus for Children With Recurrent or Progressive Low-Grade Glioma: Results From the Phase II PNOC001 Trial is a research paper published in Journal of Clinical Oncology (2023). On theSindex it has a DataRank of 0.773. It has been cited 26 times, with 21 citing works in its 1-hop citation network.
Scored on demand from live citation data
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.494
From this paper's citation signal
Citation Network Contribution
0.278
From 13 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 21 citers.
National Institutes of Health
Grant: 5U01CA168878-02
Extracellular Sulfatases As Novel Biomarkers For Early Detection of Cancer
National Institutes of Health
Grant: 5P50CA097257-12
BRAIN TUMOR SPORT GRANT
National Institutes of Health
Grant: 5R01NS091620-04
Precision Medicine For Pediatric Low-Grade Gliomas
National Institutes of Health
Grant: 5P50CA165962-09
SPORE: Targeted Therapies for Glioma
Fields of Study
Keywords